STAT3 and glioblastoma: STAT3 inhibition, or a combination of STAT3 inhibitor and radiotherapy, leads to immune reprogramming of TME in a mouse model of radioactive genetic immunity in GBM, which contributes to the interaction of DC cells and T cells, as well as antigen presentation.